SEARCH

SEARCH BY CITATION

References

  • Basta N (2011) The epidemiology of Neisseria meningitidis carriage in Bamako, Mali prior to the introduction of a newly developed meningococcal serogroup A vaccine. Thesis for the Degree of Doctor of Philosophy, University of Washington.
  • Bennett JS, Jolley KA, Earle SG et al. (2012) A genomic approach to bacterial taxonomy: an examination and proposed reclassification of species within the genus Neisseria. Microbiology 158, 15701580.
  • Boisier P, Nicolas P, Djibo S et al. (2007) Meningococcal meningitis: unprecedented incidence of serogroup X-related cases in 2006 in Niger. Clinical Infectious Diseases 44, 657663.
  • Broome CV, Rugh MA, Yada AA et al. (1983) Epidemic group C meningococcal meningitis in Upper Volta 1979. Bulletin of the World Health Organization 61, 325330.
  • Carlone GM, Frasch CE, Siber GR et al. (1992) Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay. Journal of Clinical Microbiology 30, 154159.
  • Claus H, Maiden MC, Maag R et al. (2002) Many carried meningococci lack the genes required for capsule synthesis and transport. Microbiology 148, 18131819.
  • Decosas J & Koama JB (2002) Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso. Lancet Infectious Diseases 2, 763765.
  • Dellicour S & Greenwood B (2007) Impact of meningococcal vaccination on pharyngeal carriage of meningococci. Tropical Medical and International Health 12, 14091421.
  • Djingarey MH, Barry R, Bonkoungou M et al. (2012) Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience. Vaccine 30(suppl 2), B40B45.
  • Frasch C, Preziosi MP & Laforce FM (2012) Development of a group A meningococcal conjugate vaccine, MenAfriVac. Human Vaccine Immunotherapy 8, 715724.
  • Greenwood BM (1999) Meningococcal meningitis in Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene 93, 341353.
  • Halperin SA, Bettinger JA, Greenwood B et al. (2012) The changing and dynamic epidemiology of meningococcal disease. Vaccine 30(suppl 2), B26B36.
  • Harrison OB, Claus H, Jian Y et al. (2013) Description and nomenclature of Neisseria meningitidis capsule locus. Emerging Infectious Diseases 19, 566573.
  • Holder PK, Maslanka SE, Pais LB et al. (1995) Assignment of Neisseria meningitidis group A and C class specific anticapsular antibody concentrations to the new standard reference serum CDC1992. Clinical Diagnostic Laboratory Immunology 2, 132137.
  • Jolley KA & Maiden MC (2010) BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 11, 595.
  • Jolley KA, Bliss CM, Bennett JS et al. (2012) Ribosomal multi-locus sequence typing: universal characterization of bacteria from domain to strain. Microbiology 158, 10051015.
  • Kristiansen PA, Diomandé F, Wei SC et al. (2011) Baseline meningococcal carriage in Burkina Faso before the introduction of a meningococcal serogroup A conjugate vaccine. Clinical Vaccine Immunology 18, 435453.
  • Kristiansen PA, Ouédraogo AS, Sanou I et al. (2012) Laboratory quality control in a multicentre meningococcal carriage study in Burkina Faso. Transactions of the Royal Society of Tropical Medicine and Hygiene 106, 189297.
  • Kristiansen PA, Diomandé F, Ba AK et al. (2013) Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clinical Infectious Diseases 56, 354363.
  • Lapeyssonie L (1963) La méningite cérébrospinale en Afrique. Bulletin of the World Health Organization 28(suppl), 3114.
  • Leimkugel J, Hodgson A, Forgor AA et al. (2007) Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight-year longitudinal study in northern Ghana. PloS Medicine 4, e101.
  • Lin LI (1989) A concordance correlation coefficient to evaluate reproducibility. Biometrics, 45, 255268.
  • Maiden MCJ, Stuart JM & UK Meningococcal Carriage Group (2002) Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 359, 18291830.
  • Martin JE, Armstrong JH & Smith PB (1974) New system for cultivation of Neisseria gonorrhoeae. Applied Microbiology 27, 802805.
  • Maslanka SE, Gheesling LL, Libutti DE et al. (1997) Standardization and a multilaboratory comparison of Neisseria meningitidis group A and C serum bactericidal assays. The Multilaboratory Study Group. Clinical Diagnostic Laboratory Immunology 4, 156167.
  • Mueller JE, Sangaré L, Njanpop-Lafourcade B-M et al. (2007) Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso 2003. Emerging Infectious Diseases 13, 847854.
  • Novak RT, Kambou JL, Diomandé FV et al. (2012) Serogroup A meningococcal conjugate vaccination in Burkina Faso: analysis of national surveillance data. Lancet Infectious Diseases 12, 757764.
  • Paulsen A, Overgaard S & Lauritsen JM (2012) Quality of data entry using single entry, double entry and automated forms processing - an example based on a study of patient-reported outcomes. PLoS ONE 7, e35087.
  • Pérez JL, Pulido A, Pantozzi F et al. (1990) Butyrate esterase (4-methylumberllifery butyrate) spot test, a simple method for immediate identification of Moraxella (Branhamella) catarrhalis. Journal of Clinical Microbiology 28, 23472348.
  • Sow SO, Okoko BJ, Diallo A et al. (2011) Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. New England Journal of Medicine 364, 22933204.
  • Takahashi H, Kuroki T, Watanabe Y et al. (2004) Reliability of the detection of meningococcal gamma-glutamyl transpeptidase as an identification marker for Neisseria meningitidis. Microbiological Immunology 48, 485487.
  • Trotter CL & Greenwood BM (2007) Meningococcal carriage in the African meningitis belt. Lancet Infectious Diseases 7, 797803.
  • Trotter CL, Andrews NJ, Kaczmarski EB et al. (2004) Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 364, 365367.
  • WHO Working Group (1998) Control of epidemic meningococcal disease: WHO practical guidelines. Fondation Marcel Mérieux, Lyon.
  • World Health Organization (2009). Laboratory methods for the diagnosis of meningitis caused by Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae. 2nd edn, WHO/IVB.11.09, Geneva.